当前位置: 首页 > 期刊 > 《健康大视野·医学分册》 > 2019年第8期
编号:13317175
索利那新联合PKRP治疗前列腺增生合并膀胱过度活动症的疗效分析(1)
http://www.100md.com 2019年4月15日 《健康大视野》 2019年第8期
     【摘 要】目的:观察前列腺增生(BPH)伴膀胱过度活动症(OAB)予以索利那新联合经尿道前列腺等离子双极电切术(PKRP)治疗效果。方法:选择2016.4~2017.8收治的50例BPH合并OAB者,患者均予以PKRP治疗,等分为甲、乙组,乙组在PKRP治疗基础上联合索利那新,对比两组疗效。结果:乙组治疗优良率为96.0%,较高于甲组72.0%(<0.05);治疗后,乙组症状评分,残余尿量和尿流动力学参数指标均优于同期甲组(<0.05或<0.01)。结论:BPH合并OAB患者给予PKRP治疗后,口服索利那新,优化疗效,值得推广。

    【关键词】前列腺增生;膀胱过度活动症;索利那新;PKRP;疗效观察

    Therapeutic effect of solinaxin combined with PKRP in the treatment of benign prostatic hyperplasia with overactive bladder

    Abstract:Objective To observe the therapeutic effect of solinaxine combined with transurethral plasma bipolar resection of prostate (PKRP) on benign prostatic hyperplasia (BPH) with overactive bladder (OAB).Methods: 50 cases of BPH with OAB were selected from April 2016 to August 2017.All patients were treated with PKRP.They were divided into group A and B.Group B was treated with solinaxin on the basis of PKRP ......
1 2下一页

您现在查看是摘要页,全文长 3440 字符